Victorian MP Georgie Purcell calls out hospital act
A politician has called out hospital staff who refuse medical treatment based on their religious beliefs.
Georgie Purcell, a Victorian MP from the Animal Justice Party, recently opened up in parliament about the fact she needed her copper IUD, a birth control implant, removed.
It had lodged itself in her uterus wall, and had created a risk of perforating it.
'In order for it to proceed, I had to have the procedure at a non-religious hospital,' she said.
'All over Victoria, there are hospitals conscientiously objecting to all reproductive healthcare services for women and gender diverse people.'
She said the institutions were receiving taxpayer funds but legally could deny those services.
Ms Purcell, who initially shared her personal experience and frustration with the medical system in February, said in a recent social media video that since sharing her experience she has been contacted by people in 'droves' including many with 'similar experiences'.
'Women who were denied contraception after giving birth. Women who had to terminate wanted pregnancies for medical reasons forced to seek out another hospital to accept them,' she said.
'Women who are hospitalised for emergencies and denied their prescription birth control while in the hospital bed, in the public system where patients can't choose their provider or are literally zoned to them due to location. Hospitals should not be allowed to deny essential, and sometimes life saving healthcare services.
'In fact, medical care should never be shaped by any imposed religious faith. I reiterate the need for the Victorian government to end institutional conscientious objections and ensure fair, equal and compassionate access to healthcare for every Victorian across our state.'
Ms Purcell's video struck a chord with Victorians, with many sharing their own stories and opinions. Many were shocked that this was even a reality in Australia.
'As a religious individual, religious beliefs have no place in healthcare. Hospitals should provide all healthcare, not just religious-specific healthcare,' one social media user said.
One commented: 'This is absolutely insane and NOT OK!!!'
'Now THIS is a topic that would change my vote. Free, accessible, healthcare for all. Not $50 for a GP visit, not hospitals denying care, not even non-cosmetic dental costing a cent. Is any party actually backing this,' one said.
Another added: 'Hospitals that receive ANY public funding should not have any religious affiliation at all. Ever.'
'A doctor wouldn't give me the pill at my appointment because of her religion if I'd known I would have booked another doctor,' one shared.
One social media user commented: 'Ridiculous in Australia. If they get government funding they should give equal care … but as women we don't know our bodies so men need to decide don't they?'
'Wow this is happening in Australia, I really thought the start of the video was going to be another country. Religion shouldn't be involved in healthcare or politics,' one said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Age
6 hours ago
- The Age
The collateral damage from Monash IVF's colossal embryo bungles
The next part of the script unusually involves activists calling for enhanced regulation or better laws. Advocates are also lobbying for all those who use assisted reproductive technology to have their babies DNA tested, which, if implemented, could uncover if other mistakes have gone undetected. And no scandal is complete without a politician or two making some hay by grabbing a microphone and castigating the culprits. Victorian Health Minister Mary-Anne Thomas was the first to step up this week, calling the embryo mix-up 'completely unacceptable'. 'It's very clear to me that the board of Monash IVF needs to have a very good look at what's going on,' Thomas said. Loading 'Clearly their clinical governance standards are not what they should be.' But amid the outrage there is another group that will also sustain collateral damage – the shareholders – although sympathy for this group will be way more muted. They have seen the share price of Monash IVF plunge after the first incident was revealed in April and after the company cut its 2025 full-year profit guidance by 11 per cent. It took another dive this week when the second implant bungle was revealed, taking this calendar year's stock performance down by 50 per cent. The shares kicked up by 5.7 per cent on Thursday on the news of the departing chief, but this represents a small recovery. Enter the investment bank analysts who use their sophisticated models to provide commentary on the impacts of these types of events on a company's market share and future earnings. In the case of Monash, their opinions run the gamut of possibilities. RBC Capital markets suggests that the fallout from the original bungle in Monash's Queensland clinic would confine the loss of market share to that state, and not impact too heavily on other state operations. But given there have now been two separate embryo transfer incidents in different states, it believes there is risk of a greater impact of a spread of reputational damage and market share losses. It has a negative stance on the stock. Macquarie Equities has a somewhat different view. It acknowledges the reputational damage, but says the stock is oversold and represents a good buying opportunity. You could characterise its advice as 'don't throw the baby out with the bathwater'.
Sydney Morning Herald
6 hours ago
- Sydney Morning Herald
The collateral damage from Monash IVF's colossal embryo bungles
The next part of the script unusually involves activists calling for enhanced regulation or better laws. Advocates are also lobbying for all those who use assisted reproductive technology to have their babies DNA tested, which, if implemented, could uncover if other mistakes have gone undetected. And no scandal is complete without a politician or two making some hay by grabbing a microphone and castigating the culprits. Victorian Health Minister Mary-Anne Thomas was the first to step up this week, calling the embryo mix-up 'completely unacceptable'. 'It's very clear to me that the board of Monash IVF needs to have a very good look at what's going on,' Thomas said. Loading 'Clearly their clinical governance standards are not what they should be.' But amid the outrage there is another group that will also sustain collateral damage – the shareholders – although sympathy for this group will be way more muted. They have seen the share price of Monash IVF plunge after the first incident was revealed in April and after the company cut its 2025 full-year profit guidance by 11 per cent. It took another dive this week when the second implant bungle was revealed, taking this calendar year's stock performance down by 50 per cent. The shares kicked up by 5.7 per cent on Thursday on the news of the departing chief, but this represents a small recovery. Enter the investment bank analysts who use their sophisticated models to provide commentary on the impacts of these types of events on a company's market share and future earnings. In the case of Monash, their opinions run the gamut of possibilities. RBC Capital markets suggests that the fallout from the original bungle in Monash's Queensland clinic would confine the loss of market share to that state, and not impact too heavily on other state operations. But given there have now been two separate embryo transfer incidents in different states, it believes there is risk of a greater impact of a spread of reputational damage and market share losses. It has a negative stance on the stock. Macquarie Equities has a somewhat different view. It acknowledges the reputational damage, but says the stock is oversold and represents a good buying opportunity. You could characterise its advice as 'don't throw the baby out with the bathwater'.
Sydney Morning Herald
a day ago
- Sydney Morning Herald
‘Three strikes': Demands for answers over repeat Monash IVF bungles
'Clearly at some point in time, management is responsible because they are approving budgets and systems and everything else.' Victorian Health Minister Mary-Anne Thomas said she was open to reforms that would better safeguard patients as wider concerns over the regulation of Australia's fertility industry will be discussed by Australia's health ministers in Melbourne on Friday. 'We have recently reformed the way in which we regulate fertility services, including Monash IVF, and an investigation has commenced into what went wrong here in Melbourne,' Thomas said. 'When we're thinking about fertility care, it's such an emotional rollercoaster for so many families and people seeking to either start or grow a family, and I want to ensure that we've got regulation that's fit for purpose, and that people can have confidence in these private fertility services in which they invest so much money.' The Victorian Health Regulator has launched an investigation into the embryo mix-up at Monash IVF's Clayton clinic. Loading But Swinburne University senior lecturer in corporate law Helen Bird said the sharemarket might deliver a far quicker verdict. 'The signs aren't good that they [Monash IVF] took this seriously at the start,' she said. 'They all point to poor risk management, but they also point to poor oversight by the board. 'The board may have its justifications, but after you've done it three times, with three major issues across two states at least, then you've got more than just the odd mistake going on here. You've got a systemic issue to deal with.' Monash IVF Group's board refused to provide a statement of confidence in the company's management when asked to do so by The Age on Wednesday, saying it would not comment beyond information already released to the ASX. Australian Shareholder Association chief executive Rachel Waterhouse said Monash patients would have concerns, while investors will be asking questions about the company's oversight. 'It's a concern, because you've got to trust in management, you've got to trust in the board, and mistakes in other organisations could have quite different outcomes, but this has a huge effect on trust,' Waterhouse said. While Monash IVF Group's price increased slightly to 62¢ on Wednesday, it is still a long way from its $1.42 value in August 2024, as well as the $1.09 at which it was trading before news broke of the Brisbane embryo error on April 11. 'The price has dropped because the market lacks confidence in the current management and governance of the company. The market reacts very quickly, it's much more powerful than the law in this regard,' Swinburne's Helen Bird said. Loading 'So what the major investors are doing, I imagine, is knocking on the door and saying, 'please explain, please give us some confidence that you can get on top of these issues going forward'.' Head of medical negligence at Maurice Blackburn Tom Ballantyne said the string of issues at Monash IVF demanded stronger action by regulators. 'It's three incidents in a couple of years and all of them raise concerns about the fundamental processes in the organisation,' he said. 'Fertility treatments are provided commercially, but it's a health service and a public good and needs to live up to that, and the government and Safer Care Victoria need to ensure it does live up to that.' Compensation is typically only awarded in medical negligence cases when permanent harm can be proved, which is not the case where a person is denied the chance to have a child, or potentially when they give birth to an unintended child. Rather than result in compensation, Ballantyne said most cases are resolved by offering patients replacement or free IVF cycles, with little public accountability. 'The provider can avoid the scrutiny of an actual court case that occurs in other areas,' Ballantyne said. 'It's all done behind closed doors. And, you know, the deterrence or accountability the compensation otherwise provides, is lost.'
